• Return to Headlines

FDA Adds Boxed Warning to Plavix (BMY,SNY)

Written on Fri, 03/12/2010 - 1:37pm
By Chip Brian

3/12/2010-Dow Jones reported Friday that the U.S. Food and Drug Administration has added a boxed warning to Bristol Meyers Sqibb (NYSE:BMY) and Sanofi-Aventis's (NYSE:SNY) anti-clotting medication Plavix, alerting doctors that the product doesn't work as well in some patients.
A boxed warning is the FDA's toughest warning and appears prominently at the top of a drug's label.
"In these patients, Plavix has less effect on platelets, and therefore less ability to prevent heart attack, stroke, and cardiovascular death," the FDA said.

Keywords: Bristol meyers squibb sanof-aventis plavix fda warning

Ticker(s): BMY SNY

Contact Chip Brian



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.